Categories

We’re continuing our blog series, looking at the DNA of Codex DNA — our incredible employees and their stories. Team member: Michelle Vargas, Scientist Came aboard: March 2021 What do you do at Codex DNA? I work on the Research…

Without the ability to synthesize DNA, biotechnology would not be where it is today. In this, The Living Revolution Podcast episode, Dr. John Gill, Senior Director of Research and Development at Codex DNA, dives into the future of DNA synthesis…

Built with Biology (Formerly SynBioBeta) hosted its global synthetic biology conference in Oakland, CA last week. The conference brought together synthetic biology’s leading community of innovators, investors, and thought leaders to collaborate in solving our world’s biggest problems through biology.…

We’re continuing our blog series, looking at the DNA of Codex DNA — our incredible employees and their stories. Team member: Lixia Fu, Staff Scientist Came aboard: February 2020 What do you do at Codex DNA? I’ve been working in…

We’re continuing our blog series, looking at the DNA of Codex DNA — our incredible employees and their stories. Team member: John Gill, Senior Director of Research and Development Came aboard: April 2020 What do you do at Codex DNA?…

We’re continuing our blog series, looking at the DNA of Codex DNA — our incredible employees and their stories. Team member: Elijah Grote, Software Engineer Came aboard: November 2020. What do you do at Codex DNA? I add features and…

On Monday, January 24th, NBC 7 San Diego reporter Madison Weil interviewed Codex DNA’s CEO, Todd Nelson, to discuss our recent early access collaboration and licensing agreement with Pfizer. Under this agreement, Pfizer gains early access to Codex DNA’s proprietary…

We’re continuing our blog series, looking at the DNA of Codex DNA — our incredible employees and their stories. Team member: Yanming Gong, Director of Synthesis Came aboard: September 2021. What do you do at Codex DNA? I work in…

We’re proud of Codex DNA’s Co-Founder and CTO, Dan Gibson, for being featured in this year’s Newsweek Magazine’s America’s Greatest Disruptor list. With his team of scientists at Codex DNA, Dan Gibson is focused on creating a new paradigm for…

We’re continuing our blog series, looking at the DNA of Codex DNA — our incredible employees and their stories. Team member: Ted Alejandre. Senior Manager, Commercial Analytics Came aboard: April, 2021. What do you do at Codex DNA? I manage…

Codex DNA’s mission is to drive innovation and apply breakthroughs in automation solutions for DNA, mRNA, and protein synthesis. These tools enable scientists to “write” biology for the betterment of the world, creating sustainable healthcare and technology solutions for humanity’s…

The Codex DNA team recently attended PEGS Europe, held this year in Barcelona, Spain. With over 200 speakers including 15 keynote addresses, the conference brings together scientific professionals to discuss the latest developments in protein and antibody engineering, cell and…

It’s been one year since we launched the BioXp™ 3250 system — our fully automated biology for gene synthesis, cloning, mRNA synthesis, variant DNA libraries, and more — and we’re excited to see how much progress researchers have made with…

The Discovery on Target 2021 conference took place Sept 28-30 in Boston, bringing together several experts from across the US and globally to foster collaboration and share the latest advances in addressing key challenges in drug discovery. At this year’s…

Synthetic biology has become so important and widely used that it’s easy to forget how young the field is. Much of the innovation that we rely on today took place in just the last two decades. Codex DNA was originally…

If you’re working with synthetic mRNA, we have exciting news to share. In addition to releasing a new workflow earlier this year that makes it possible to synthesize mRNA form pooled oligos in a single overnight run on our BioXp™…

RNA Day is on Sunday, August 1st this year, and we welcome the international celebration of one of the most versatile biomolecules we have seen come to life. We have seen RNA play a key role in addressing the COVID-19…

Earlier this month, the Codex DNA team attended the RNA Society conference (all virtual in 2021) to discuss hot topics and relevant content for those responsible for leading their labs through the latest rounds of challenges and crossroads. A benefit…

Earlier this month the Codex DNA team attended the PEGS Boston Summit, held this year as a virtual event. This important conference has been around for more than 15 years and is well known as a great resource to learn…

Last week, we had the opportunity to partner with Jesse Erasmus, Acting Assistant Professor of the University of Washington School of Medicine and Director of Virology at HDT Bio, presenting a webinar titled Development of a replicon RNA vaccine platform…

BCC sits down with Jason Lehmann, PhD, from Codex DNA, Inc. in San Diego to talk about Codex DNA’s mission of applying breakthroughs in synthetic biology automation solutions. BCC podcast host Clara Mouawad and Jason talk about Codex DNA’s recent…

We’re celebrating two of the biggest discoveries in scientific history: The molecular structure of DNA and the complete mapping of all genes in the human genome The discovery of DNA’s double helix in 1953 and the completion of the Human…

The bacterial scourge of the citrus greening disease has affected citrus production worldwide, causing tree decline and a serious threat to Florida’s citrus industry. Citrus greening disease, or Huanglongbing (HLB), is caused by Candidotus liberibacter (CLass) and is spread by…

The Codex DNA team loves to get its geek on. For the past year, we’ve missed in-person conferences, but virtual events still let us get up to speed on some of the latest advances in the scientific community. Most recently,…

The Codex DNA team was delighted to participate in this year’s SLAS annual conference, held by the Society for Laboratory Automation and Screening. While our favorite part of the virtual event was getting to interact with the many attendees who…

It can be tough to keep up on the latest COVID-19 news, but a new ebook from Biocompare is here to help. The ebook offers a nice array of articles focused on how novel tools are being used to accelerate…

Scientists have made a new discovery that could eventually lead to more effective treatment for malaria. In a series of experiments that included using the BioXp™ system, they determined that a key phospholipid and a related protein confer protection against…

The next industrial revolution will be biological. By turning cells into factories, synthetic biology changes how we make everything from plastic to food to medicine. But achieving those goals will require overcoming the limitations of DNA design. This is still…

Monoclonal antibodies represent an important class of therapies for an ever-increasing number of diseases, infections, and health conditions. That’s why scientists around the world are working to improve the processes required to engineer new antibody candidates for therapeutic use. The…

Since the start of the COVID-19 pandemic, the Codex DNA team has been working hard to ensure that our customers have access to the tools they need to help in the fight against this public health scourge. We currently offer…

At a recent Oxford Global NextGen Omics UK congress, our own Kirsty Maclean gave a presentation about how the BioXp™ system is powering advances in cell engineering. While she started with a high-level view of how synthetic biology applies to…

One of the most popular applications of synthetic biology is to confer desired traits to an organism. Designing a range of possibilities and then testing each one for fitness, productivity, stability, or some other goal is critically important as the…

Back in 2013, I played a small role in response to what then seemed like the next potential pandemic — an outbreak of H7N9, an avian influenza virus. At the time, I was working with Novartis scientists, and we were…

If you were there for the early days of synthetic biology, you probably remember it the way we do: a relatively small number of academic scientists toiling in labs to build key parts, like toggle switches, and tinkering with the…

In the age of COVID-19, there has been a ton of scientific interest in nanobodies, or single-domain antibodies that can be used for finely targeted viral vaccines. It’s also been a hot topic among users of our BioXp™ system —…

Breast cancer is now recognized as the most common malignancy worldwide among women, irrespective of age. Today’s standard of care and breast cancer management relies heavily on chemotherapy, hormone therapy, and targeted therapy. However, there is still much to be…

The Codex DNA team really enjoyed attending this year’s virtual Global Synthetic Biology Conference hosted by SynBioBeta. If you missed the event, we’ve got you covered — here’s our take on highlights from the meeting. BioXp™ system in the spotlight…

For cancer patients with few other treatment options, the need for new targeted immunotherapies is genuinely a matter of life or death. So how to accelerate the development of new therapies? One key component is automated DNA synthesis. That was…

For BioXp™ system users, antibody drug discovery is one of the most popular applications. That’s why we were delighted to participate in the recent Oxford Global Biologics virtual conference, with a presentation from our own Kirsty Maclean, Director of Applications…

Several recent publications from the rockstar team at GigaGen illustrate how they are using the BioXp™ system to streamline antibody drug discovery workflows. It’s tough to overstate the importance of this area of research: monoclonal antibodies, antibody drug conjugates, and…